FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

422060001: Conventional release eye solution (dose form)


Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
2617625018 Ophthalmic solution en Synonym Active Entire term case insensitive SNOMED CT core module
3620936012 Conventional release eye solution (dose form) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3620937015 Eye solution en Synonym Active Entire term case insensitive SNOMED CT core module
3620938013 Conventional release eye solution en Synonym Active Entire term case insensitive SNOMED CT core module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Conventional release eye solution Is a Drug solution false Inferred relationship Existential restriction modifier
Conventional release eye solution Is a Ocular dose form true Inferred relationship Existential restriction modifier
Conventional release eye solution Has dose form administration method Apply true Inferred relationship Existential restriction modifier
Conventional release eye solution Has dose form intended site Ocular true Inferred relationship Existential restriction modifier
Conventional release eye solution Has dose form release characteristic Conventional release true Inferred relationship Existential restriction modifier
Conventional release eye solution Has basic dose form Solution true Inferred relationship Existential restriction modifier
Conventional release eye solution Has dose form transformation No transformation true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Dorzolamide 2% eye drops (A A H Pharmaceuticals Ltd) Has manufactured dose form True Conventional release eye solution Inferred relationship Existential restriction modifier
Acular 0.5% eye drops (Necessity Supplies Ltd) Has manufactured dose form True Conventional release eye solution Inferred relationship Existential restriction modifier
Trusopt 2% eye drops (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release eye solution Inferred relationship Existential restriction modifier
Dorzant 2% eye drops (Aspire Pharma Ltd) Has manufactured dose form True Conventional release eye solution Inferred relationship Existential restriction modifier
Dorzolamide 2% eye drops (Phoenix Healthcare Distribution Ltd) Has manufactured dose form True Conventional release eye solution Inferred relationship Existential restriction modifier
Dorzolamide 2% eye drops (Sigma Pharmaceuticals Plc) Has manufactured dose form True Conventional release eye solution Inferred relationship Existential restriction modifier
Dorzolamide 20mg/ml eye drops (Kent Pharma (UK) Ltd) Has manufactured dose form True Conventional release eye solution Inferred relationship Existential restriction modifier
Dorzolamide 20mg/ml eye drops (Accord Healthcare Ltd) Has manufactured dose form True Conventional release eye solution Inferred relationship Existential restriction modifier
Sodium chloride 5% eye drops (Alissa Healthcare Research Ltd) Has manufactured dose form True Conventional release eye solution Inferred relationship Existential restriction modifier
Dorzolamide 2% eye drops (Aspire Pharma Ltd) Has manufactured dose form True Conventional release eye solution Inferred relationship Existential restriction modifier
Dorzolamide 2% eye drops (Sandoz Ltd) Has manufactured dose form True Conventional release eye solution Inferred relationship Existential restriction modifier
Hypersal 5% eye drops (Ennogen Healthcare Ltd) Has manufactured dose form True Conventional release eye solution Inferred relationship Existential restriction modifier
Dorzolamide 2% eye drops (Waymade Healthcare Plc) Has manufactured dose form True Conventional release eye solution Inferred relationship Existential restriction modifier
Dorzolamide 2% eye drops (DE Pharmaceuticals) Has manufactured dose form True Conventional release eye solution Inferred relationship Existential restriction modifier
Dorzolamide 2% eye drops (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release eye solution Inferred relationship Existential restriction modifier
Dorzolamide 20mg/ml eye drops (Viatris UK Healthcare Ltd) Has manufactured dose form True Conventional release eye solution Inferred relationship Existential restriction modifier
Ketorolac 0.5% eye drops (A A H Pharmaceuticals Ltd) Has manufactured dose form True Conventional release eye solution Inferred relationship Existential restriction modifier
Ketorolac 0.5% eye drops (Brown & Burk UK Ltd) Has manufactured dose form True Conventional release eye solution Inferred relationship Existential restriction modifier
Ketorolac 0.5% eye drops (Alliance Healthcare (Distribution) Ltd) Has manufactured dose form True Conventional release eye solution Inferred relationship Existential restriction modifier
Dorzolamide 20mg/ml eye drops (Medicom Healthcare Ltd) Has manufactured dose form True Conventional release eye solution Inferred relationship Existential restriction modifier

Start Previous Page 3 of 3


This concept is not in any reference sets

Back to Start